Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity.
about
Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.Nonhematopoietic antigen blocks memory programming of alloreactive CD8+ T cells and drives their eventual exhaustion in mouse models of bone marrow transplantation.IL-15 Enables Septic Shock by Maintaining NK Cell Integrity and Function.Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHDIL-15 Superagonist Expands mCD8+ T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound InfectionIL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ.Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease.Hydrodynamic delivery of human IL-15 cDNA increases murine natural killer cell recovery after syngeneic bone marrow transplantationOverexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cellsIncreased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa.Transcriptional regulation of the mucosal immune system mediated by T-bet.Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia.Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.
P2860
Q33680566-0C7EF948-08E3-4B24-8F84-82247DE62AA4Q34245299-9881E12F-C51E-46D6-AEDC-CD28F2360CE9Q34548214-B74CB1B7-FB06-471C-B8CB-B2F7DC7D9ACCQ34974093-D4C40F01-4EBF-42C1-934B-9F58822925E7Q35918321-2006AC73-F9A7-4A9D-958B-72589DD02062Q35979037-CBF0C816-87EA-4D6A-9DE1-308389951CC8Q36401844-408BEB64-6660-460A-A91E-44B4C9B10350Q36423437-9596C7A2-0E03-4269-8A7C-9BA636DCEBF7Q36779403-A58385B3-11C0-4DDC-B3F1-63310CE16403Q37157967-846E9150-A3F9-4BAA-9D0E-11671A174BA3Q37789145-3ECA93BC-E339-4E8F-8BDD-3EBAECA0FC23Q38836832-AD58D9F5-E8F1-48E5-9B5C-EB2E61E3583AQ42151172-B0B69739-722D-4A1E-9926-49F165CEF6C2Q50066002-3A299133-1945-4E94-92A0-53979479EBAC
P2860
Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Trans-presentation of donor-de ...... r graft-versus-tumor activity.
@ast
Trans-presentation of donor-de ...... r graft-versus-tumor activity.
@en
type
label
Trans-presentation of donor-de ...... r graft-versus-tumor activity.
@ast
Trans-presentation of donor-de ...... r graft-versus-tumor activity.
@en
prefLabel
Trans-presentation of donor-de ...... r graft-versus-tumor activity.
@ast
Trans-presentation of donor-de ...... r graft-versus-tumor activity.
@en
P2093
P2860
P1433
P1476
Trans-presentation of donor-de ...... r graft-versus-tumor activity.
@en
P2093
Amy K Ferketich
Bradley W Blaser
Brian Becknell
Dennis Chang
Donna F Kusewitt
Michael A Caligiuri
Noah R Schwind
Sameek Roychowdhury
Samuel Shin
P2860
P304
P356
10.1182/BLOOD-2006-04-019059
P407
P577
2006-06-06T00:00:00Z